Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Arrhythmias

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    March 2023
  1. CHESKES S, Dorian P, Scales DC
    Defibrillation Strategies for Refractory Ventricular Fibrillation. Reply.
    N Engl J Med. 2023;388:861-863.
    PubMed    


  2. WITTIG J, Lofgren B, Lauridsen KG
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2023;388:861-862.
    PubMed    


  3. CAZES N, Meyran D, Boutillier du Retail C
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2023;388:861.
    PubMed    


  4. KOSTER RW
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2023;388:861.
    PubMed    


  5. KATZENSCHLAGER S, Elshaer A, Spoettl W
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2023;388:860.
    PubMed    


    January 2023
  6. SUVEREIN MM, Delnoij TSR, Lorusso R, Brandon Bravo Bruinsma GJ, et al
    Early Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest.
    N Engl J Med. 2023;388:299-309.
    PubMed     Abstract available


  7. SANDHU RK, Albert CM
    First-Line Catheter Ablation for Paroxysmal Atrial Fibrillation - Have We Reached the Tipping Point?
    N Engl J Med. 2023;388:177-178.
    PubMed    


    December 2022
  8. KARTHIKEYAN G, Connolly SJ, Yusuf S
    Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. Reply.
    N Engl J Med. 2022;387:2100-2101.
    PubMed    


  9. PROVIDENCIA R
    Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
    N Engl J Med. 2022;387:2100.
    PubMed    


  10. HAMMER A, Niessner A, Sulzgruber P
    Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
    N Engl J Med. 2022;387:2100.
    PubMed    


    November 2022
  11. ANDRADE JG, Deyell MW, Macle L, Wells GA, et al
    Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.
    N Engl J Med. 2022 Nov 7. doi: 10.1056/NEJMoa2212540.
    PubMed     Abstract available


  12. CHESKES S, Verbeek PR, Drennan IR, McLeod SL, et al
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2207304.
    PubMed     Abstract available


    October 2022
  13. ANTMAN EM, Leopold JA, Sauer WH, Zei PC, et al
    Atrial Fibrillation - What Is It and How Is It Treated?
    N Engl J Med. 2022;387:e38.
    PubMed    


  14. ANTMAN EM, Leopold JA, Sauer WH, Zei PC, et al
    Atrial Fibrillation and Catheter Ablation.
    N Engl J Med. 2022;387:e31.
    PubMed    


    September 2022
  15. MCCULLOUGH J, Perera RG
    Arrhythmogenic Right Ventricular Cardiomyopathy.
    N Engl J Med. 2022;387:e20.
    PubMed    


    August 2022
  16. CONNOLLY SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, et al
    Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
    N Engl J Med. 2022 Aug 28. doi: 10.1056/NEJMoa2209051.
    PubMed     Abstract available


  17. FRIEDMAN P, Murgatroyd F, Boersma LVA, Manlucu J, et al
    Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
    N Engl J Med. 2022 Aug 28. doi: 10.1056/NEJMoa2206485.
    PubMed     Abstract available


  18. LIP GYH
    Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease.
    N Engl J Med. 2022 Aug 28. doi: 10.1056/NEJMe2210187.
    PubMed    


  19. LEE C, Rosenqvist M, Mandrola J
    Screening for Atrial Fibrillation in Asymptomatic Older Adults.
    N Engl J Med. 2022;387:565-567.
    PubMed    


  20. AKHMEROV A, Ramzy D
    Left Atrial Thrombus.
    N Engl J Med. 2022;387:e8.
    PubMed    


    April 2022
  21. PARAS ML, Khurshid S, Foldyna B, Huang AL, et al
    Case 13-2022: A 56-Year-Old Man with Myalgias, Fever, and Bradycardia.
    N Engl J Med. 2022;386:1647-1657.
    PubMed    


  22. GARFINKEL AC
    From Resentment to Reconnection - Reflections on Caring for the Unvaccinated.
    N Engl J Med. 2022;386:1394-1395.
    PubMed    


    February 2022
  23. VAN MIEGHEM NM, Unverdorben M, Dangas GD
    Edoxaban or Vitamin K Antagonist for Atrial Fibrillation after TAVR. Reply.
    N Engl J Med. 2022;386:804.
    PubMed    


  24. HUDAIB AR
    Edoxaban or Vitamin K Antagonist for Atrial Fibrillation after TAVR.
    N Engl J Med. 2022;386:803-804.
    PubMed    


    October 2021

  25. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2021;385:1632.
    PubMed    



  26. Early Rhythm Control in Atrial Fibrillation.
    N Engl J Med. 2021;385:1632.
    PubMed    


    September 2021
  27. SANDBORN WJ, Feagan BG, D'Haens G, Wolf DC, et al
    Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2021;385:1280-1291.
    PubMed     Abstract available


    August 2021
  28. VAN MIEGHEM NM, Unverdorben M, Hengstenberg C, Mollmann H, et al
    Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
    N Engl J Med. 2021 Aug 28. doi: 10.1056/NEJMoa2111016.
    PubMed     Abstract available


    July 2021
  29. KADIRE SR, Al-Khatib SM, Calkins H
    Anticoagulation after Ablation for Atrial Fibrillation.
    N Engl J Med. 2021;385:466-468.
    PubMed    


  30. KRATKA A, Yozamp N, Vaidya A, Marqusee E, et al
    A Periodic Problem.
    N Engl J Med. 2021;385:e17.
    PubMed    


  31. MICHAUD GF, Stevenson WG
    Atrial Fibrillation. Reply.
    N Engl J Med. 2021;385:383-384.
    PubMed    


  32. MATOS JD, Gavin MC, Gelfand EV
    Atrial Fibrillation.
    N Engl J Med. 2021;385:383.
    PubMed    


  33. BEN SALEM C
    Atrial Fibrillation.
    N Engl J Med. 2021;385:383.
    PubMed    


  34. DORIAN P, Angaran P
    Atrial Fibrillation.
    N Engl J Med. 2021;385:382-383.
    PubMed    


  35. HUMPHRIES R, Cameron M
    Lingual-Artery Thromboembolism.
    N Engl J Med. 2021;385:65.
    PubMed    


  36. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    


    June 2021
  37. ZIMERMAN A, d'Avila A
    Speech-Induced Atrial Tachycardia.
    N Engl J Med. 2021;384:e83.
    PubMed    


    May 2021
  38. MARINE JE
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed    


  39. WAZNI OM, Sood N, Nissen SE
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed    


  40. ANDRADE JG, Deyell MW, Verma A
    Cryoablation as Initial Therapy for Atrial Fibrillation. Reply.
    N Engl J Med. 2021;384:e82.
    PubMed    


  41. GALES L, Lipsker D
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed    


  42. DIMARCO A, Lavesa-Cesana J
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed    


  43. PROIETTI R, Vio R, Lip GYH
    Cryoablation as Initial Therapy for Atrial Fibrillation.
    N Engl J Med. 2021;384:e82.
    PubMed    


  44. LAU ES, Vaidya A, Schaefer IM, Scirica BM, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:e80.
    PubMed    


  45. WHITLOCK RP, Belley-Cote EP, Paparella D, Healey JS, et al
    Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.
    N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2101897.
    PubMed     Abstract available


    April 2021
  46. SCOTT NS, Thomas SS, DeFaria Yeh D
    Case 2-2021: A Pregnant Woman with Ventricular Tachycardia and Shock. Reply.
    N Engl J Med. 2021;384:e64.
    PubMed    


  47. BOGATY P
    Case 2-2021: A Pregnant Woman with Ventricular Tachycardia and Shock.
    N Engl J Med. 2021;384:e64.
    PubMed    


  48. KASSIR R
    Intrapericardial Colon.
    N Engl J Med. 2021;384:e49.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: